These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 16503253

  • 1. CD40 ligand and risk of ischemic stroke or coronary events in patients with chronic coronary heart disease.
    Tanne D, Haim M, Goldbourt U, Boyko V, Reshef T, Adler Y, Benderly M, Mekori YA, Behar S.
    Int J Cardiol; 2006 Mar 08; 107(3):322-6. PubMed ID: 16503253
    [Abstract] [Full Text] [Related]

  • 2. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study.
    Kinlay S, Schwartz GG, Olsson AG, Rifai N, Sasiela WJ, Szarek M, Ganz P, Libby P, Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators.
    Circulation; 2004 Jul 27; 110(4):386-91. PubMed ID: 15262833
    [Abstract] [Full Text] [Related]

  • 3. C-reactive protein, bezafibrate, and recurrent coronary events in patients with chronic coronary heart disease.
    Haim M, Benderly M, Tanne D, Matas Z, Boyko V, Fisman EZ, Tenenbaum A, Zimmlichman R, Battler A, Goldbourt U, Behar S.
    Am Heart J; 2007 Dec 27; 154(6):1095-101. PubMed ID: 18035081
    [Abstract] [Full Text] [Related]

  • 4. Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation.
    Ferro D, Loffredo L, Polimeni L, Fimognari F, Villari P, Pignatelli P, Fuster V, Violi F.
    Arterioscler Thromb Vasc Biol; 2007 Dec 27; 27(12):2763-8. PubMed ID: 17901373
    [Abstract] [Full Text] [Related]

  • 5. Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease.
    Tanne D, Haim M, Goldbourt U, Boyko V, Doolman R, Adler Y, Brunner D, Behar S, Sela BA.
    Stroke; 2003 Mar 27; 34(3):632-6. PubMed ID: 12624283
    [Abstract] [Full Text] [Related]

  • 6. The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromes.
    Yan JC, Zhu J, Gao L, Wu ZG, Kong XT, Zong RQ, Zhan LZ.
    Clin Chim Acta; 2004 May 27; 343(1-2):155-9. PubMed ID: 15115688
    [Abstract] [Full Text] [Related]

  • 7. Serum complement C3/C4 ratio, a novel marker for recurrent cardiovascular events.
    Palikhe A, Sinisalo J, Seppänen M, Haario H, Meri S, Valtonen V, Nieminen MS, Lokki ML.
    Am J Cardiol; 2007 Apr 01; 99(7):890-5. PubMed ID: 17398178
    [Abstract] [Full Text] [Related]

  • 8. Soluble CD40L: risk prediction after acute coronary syndromes.
    Varo N, de Lemos JA, Libby P, Morrow DA, Murphy SA, Nuzzo R, Gibson CM, Cannon CP, Braunwald E, Schönbeck U.
    Circulation; 2003 Sep 02; 108(9):1049-52. PubMed ID: 12912804
    [Abstract] [Full Text] [Related]

  • 9. Serum homocysteine and long-term risk of myocardial infarction and sudden death in patients with coronary heart disease.
    Haim M, Tanne D, Goldbourt U, Doolman R, Boyko V, Brunner D, Sela BA, Behar S.
    Cardiology; 2007 Sep 02; 107(1):52-6. PubMed ID: 16763372
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, Hsia J, Gersh BJ, Rifai N, Ridker PM, Pfeffer MA, Braunwald E, PEACE Investigators.
    Circulation; 2007 Mar 27; 115(12):1528-36. PubMed ID: 17372173
    [Abstract] [Full Text] [Related]

  • 11. Prognosis of patients with atherothrombotic disease: a prospective survey in a non-hospital setting.
    Ferrières J, Cambou JP, Gayet JL, Herrmann MA, Leizorovicz A.
    Int J Cardiol; 2006 Oct 10; 112(3):302-7. PubMed ID: 16325285
    [Abstract] [Full Text] [Related]

  • 12. Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease.
    Lim PS, Wu MY, Chien SW, Wu TK, Liu CS, Hu CY, Chang HC, Pai MA.
    Nephrology (Carlton); 2008 Dec 10; 13(8):677-83. PubMed ID: 19019166
    [Abstract] [Full Text] [Related]

  • 13. C-reactive protein predicts further ischemic events in transient ischemic attack patients.
    Purroy F, Montaner J, Molina CA, Delgado P, Arenillas JF, Chacon P, Quintana M, Alvarez-Sabin J.
    Acta Neurol Scand; 2007 Jan 10; 115(1):60-6. PubMed ID: 17156267
    [Abstract] [Full Text] [Related]

  • 14. Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults: the cardiovascular health study.
    Lemaitre RN, King IB, Mozaffarian D, Sotoodehnia N, Rea TD, Kuller LH, Tracy RP, Siscovick DS.
    Circulation; 2006 Jul 18; 114(3):209-15. PubMed ID: 16818809
    [Abstract] [Full Text] [Related]

  • 15. Soluble CD154 is a unique predictor of nonfatal and fatal atherothrombotic events in patients who have end-stage renal disease and are on hemodialysis.
    Hocher B, Liefeldt L, Quaschning T, Kalk P, Ziebig R, Godes M, Relle K, Asmus G, Stasch JP.
    J Am Soc Nephrol; 2007 Apr 18; 18(4):1323-30. PubMed ID: 17314326
    [Abstract] [Full Text] [Related]

  • 16. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I, Benderly M, Sidi R, Boyko V, Tenenbaum A, Tanne D, Behar S.
    Am J Cardiol; 2009 Jan 01; 103(1):41-5. PubMed ID: 19101227
    [Abstract] [Full Text] [Related]

  • 17. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events.
    Healy AM, Pickard MD, Pradhan AD, Wang Y, Chen Z, Croce K, Sakuma M, Shi C, Zago AC, Garasic J, Damokosh AI, Dowie TL, Poisson L, Lillie J, Libby P, Ridker PM, Simon DI.
    Circulation; 2006 May 16; 113(19):2278-84. PubMed ID: 16682612
    [Abstract] [Full Text] [Related]

  • 18. Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study.
    Engström G, Hedblad B, Janzon L, Lindgärde F.
    Eur J Cardiovasc Prev Rehabil; 2007 Jun 16; 14(3):392-7. PubMed ID: 17568238
    [Abstract] [Full Text] [Related]

  • 19. White blood cell count predicts reduction in coronary heart disease mortality with pravastatin.
    Stewart RA, White HD, Kirby AC, Heritier SR, Simes RJ, Nestel PJ, West MJ, Colquhoun DM, Tonkin AM, Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID) Study Investigators.
    Circulation; 2005 Apr 12; 111(14):1756-62. PubMed ID: 15809366
    [Abstract] [Full Text] [Related]

  • 20. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women.
    Fung TT, Chiuve SE, McCullough ML, Rexrode KM, Logroscino G, Hu FB.
    Arch Intern Med; 2008 Apr 14; 168(7):713-20. PubMed ID: 18413553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.